CN108392183B - In-vivo and in-vitro electrocardiosignal transmission system - Google Patents
In-vivo and in-vitro electrocardiosignal transmission system Download PDFInfo
- Publication number
- CN108392183B CN108392183B CN201810136461.XA CN201810136461A CN108392183B CN 108392183 B CN108392183 B CN 108392183B CN 201810136461 A CN201810136461 A CN 201810136461A CN 108392183 B CN108392183 B CN 108392183B
- Authority
- CN
- China
- Prior art keywords
- transmission device
- mobile electronic
- electrocardio
- signal transmission
- module
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
- A61B5/0006—ECG or EEG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Cardiology (AREA)
- Electrotherapy Devices (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
The invention discloses an in-vivo and in-vitro electrocardiosignal transmission system. The system comprises an implantable electrocardio device, an electrocardio signal transmission device and a mobile electronic device; the electrocardiosignal transmission device is connected with the mobile electronic equipment; the mobile electronic equipment is connected with a hospital database, and an APP with an emergency call function is installed on the mobile electronic equipment. The in-vivo and in-vitro electrocardiosignal transmission system is based on the mobile electronic equipment, and can inform a hospital at the first time when a patient is sick, and the follow-up visit of the patient in a conventional hospital is avoided.
Description
Technical Field
The invention relates to the technical field of medical instruments, in particular to an in-vivo and in-vitro electrocardiosignal transmission system.
Background
Patients with bradycardia and tachycardia require frequent doctor visits after implantation of a pacemaker and a defibrillator. The traditional follow-up mode is that the patient visits the hospital once every half year. In China, medical resources are concentrated in a plurality of major cities, and disease sources are distributed nationwide, so that the follow-up mode is time-consuming and labor-consuming and is a burden for patients. For implantable cardiac defibrillator patients, the defibrillator needs to be checked by the physician immediately after discharge. Such an approach tends to delay treatment. On the other hand, most of the patients in China at present need to read data by a doctor in a mode of coupling coils inside and outside the body.
At present, the prior art gradually starts to support the wireless communication function between the pacemaker and the implant, and adopts a relay station (bluetooth) mode to remotely transmit the electrocardiographic information of the patient. Thus, the patient can be followed without going out. However, this method is limited in that data cannot be transmitted when the patient is far away from the relay station. The high price (only high-end products are equipped) and the additional overhead (cost of the relay station) are burdensome to the patient.
Therefore, there is an urgent need in the art to develop a new inexpensive and convenient in vivo and vitro electrocardiosignal transmission system.
Disclosure of Invention
The invention aims to provide an electrocardiosignal transmission system which is low in price and convenient based on mobile equipment.
In the invention, the invention provides an electrocardiosignal transmission system. The system comprises an implanted electrocardio device, an electrocardiosignal transmission device and a mobile electronic device,
the electrocardiosignal transmission device is connected with the mobile electronic equipment;
the mobile electronic equipment is connected with a hospital database, and an APP with an emergency call function is installed on the mobile electronic equipment.
The electrocardiosignal transmission device is connected with the mobile electronic equipment through a USB.
The USB is standard USB or Mini USB.
The implantable electrocardiograph device comprises a first RF module, and the first RF module is used for communicating with the electrocardiograph signal transmission device.
The implantable electrocardiograph device comprises a first control unit, and the first control unit is used for controlling the operation of the implantable electrocardiograph device.
The electrocardiosignal transmission device comprises a second control unit, and the second control unit is used for controlling the work of the electrocardiosignal transmission device.
The electrocardiosignal transmission device comprises a second RF module.
The electrocardiosignal transmission device also comprises a USB communication module, and the electrocardiosignal transmission device is communicated with the mobile electronic equipment through the USB communication module.
The electrocardiosignal transmission device is installed on the mobile electronic equipment.
The electrocardiosignal transmission device also comprises an alarm module.
The electrocardiosignal transmission device is provided with a distance monitoring module which is used for monitoring the distance between the implanted electrocardio equipment and the mobile electronic equipment.
It is to be understood that within the scope of the present invention, the above-described features of the present invention and those specifically described below (e.g., in the examples) may be combined with each other to form new or preferred embodiments. Not to be reiterated herein, but to the extent of space.
The main advantages of the invention include:
(a) the in-vivo and in-vitro electrocardiosignal transmission system is based on the mobile electronic equipment, and can inform a hospital at the first time when a patient is ill;
(b) the in-vivo and in-vitro electrocardiosignal transmission system avoids the conventional hospital follow-up visit of patients, and replaces the conventional hospital follow-up visit with the 'follow-up visit as required and in time';
(c) the in-vivo and in-vitro electrocardiosignal transmission system is based on mature mobile electronic equipment (such as a mobile phone), and the whole data transmission system is low in cost and high in maintainability.
Drawings
Fig. 1 is a schematic structural diagram of an embodiment of an electrocardiograph signal transmission system according to the present invention.
Detailed Description
The inventor of the invention has studied extensively and deeply and developed an electrocardiosignal transmission system based on mobile electronic equipment for the first time. The system includes an implantable electrocardiograph device (e.g., ICD), a signal transmission apparatus external to the body, and a removable electronic device. The device is arranged on a mobile electronic device which is convenient for a user to carry, or is arranged at a place which the user frequently goes, such as a study room, a bedroom and the like. The device can wake up the ICD in the user body in a common monitoring state and read the data of the ICD in the user body; or in the emergency monitoring state, the ICD in the user body wakes up the electrocardiosignal transmission device and enables the device to read the data of the ICD in the user body. Once the ICD in the user's body detects the unusual situation, it starts actively looking for a transmitting device. If not found, the ICDs are processed (namely the states of most ICDs on the market at present); if the transmission device is found, the following three actions are carried out simultaneously: 1. immediately informing the hospital for emergency treatment; 2. the electrocardio data is transmitted to a big data platform in real time, and the big data platform algorithm assists judgment; 3. from the abnormality, all data enter the data platform until normal stable electrocardio is monitored. The mobile electronic device may be a mobile phone, a tablet computer, a sports bracelet or a smart phone watch, etc. The electrocardiosignal transmission device can be provided with a position monitoring module and an alarm module, and once the situation that the user leaves a good signal range between the electrocardiosignal transmission device and the user is monitored, an alarm is given out to remind the user. The mobile electronic equipment can be used as a cloud service system, is connected with a hospital database, and is used for carrying out first-aid information processing and first-aid signal distress. The cardiac signal transmission device may be configured to resemble a credit card reader in appearance, customized to an RF small base station.
The present invention has been completed based on this finding.
Term(s) for
As used herein, the term "ICD" refers to an Implantable automatic defibrillation device (ICD). Two thin electrical wires connect the ICD to one or more ventricles in the heart. The heart sends electrical signals to the ICD. If the heart beats disorderly and too fast, the ICD will deliver an electrical pulse or shock to the heart to restore a normal heart rhythm. Defibrillation is a method of normalizing an excessively fast or irregular heart rhythm by an electric shock.
The system comprises an implantable electrocardio device (pacemaker and defibrillator) with a radio frequency communication function, an external RF small base station and a mobile electronic device such as a mobile phone. The RF small base station is connected with the mobile phone through a standard USB or a Mini USB; the mobile phone supports connection with a hospital database, and the mobile phone is provided with an APP with an emergency call function.
1. Implantable cardiac electric device (pacemaker, defibrillator)
The MCU control unit is responsible for controlling the work of the whole implantable electrocardio device.
The Communication between the RF module and the RF base station adopts the standard of 400MHz Medical Implant Communication Service (MICS), and the general Communication distance is 2-5 m. The RF module has 2 operating states:
the first state is a normal operating state. In this state, the RF module is sleeping most of the time to save the battery, but searches every 1 second for the presence of a wake-up signal from the external RF base station. If the wake-up signal is searched, the system immediately enters an operating state, establishes connection with an external RF base station and communicates under the control of the external RF base station. This condition is used primarily during a doctor's remote follow-up.
The second state is an emergency operating state. At the moment, the MCU finds the abnormal electrocardio of the patient, immediately wakes up the RF module to start searching the in-vitro RF base station and establishes wireless connection. And after the connection is finished, the first-aid information and the electrocardiogram data are sent to the base station.
2. RF base station
The RF base station consists of three main modules.
The MCU control unit controls the working state of the base station to complete the information conversion between the RF module and the USB communication module.
The RF module is in a standby state at ordinary times and waits for an active communication request sent by the smart phone or an emergency connection request of the implantable electrocardio device. After establishing wireless connection with the implantable electrocardiograph device, the required information is exchanged according to the communication protocol.
The USB communication module is responsible for communication between the RF base station and the smart phone, and takes power from a USB interface of the smart phone to supply power to the RF base station.
3. Intelligent electronic device
Such as a smart phone, communicates with and powers the RF base station via a USB connection.
The APP on the smart phone can command the RF base station to actively initiate communication, and then the implantable electrocardio device is required to return parameters such as state information. The emergency information of the implanted electrocardio equipment can be passively monitored, after the emergency information is received, a hospital emergency call is immediately dialed, and simultaneously all abnormal electrocardiosignals are uploaded to a hospital database through WIFI or mobile phone data traffic.
The invention will be further illustrated with reference to the following specific examples. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. The experimental procedures, in which specific conditions are not noted in the following examples, are generally carried out under conventional conditions or conditions recommended by the manufacturers. Unless otherwise indicated, percentages and parts are percentages and parts by weight.
It is to be noted that in the claims and the description of the present patent, relational terms such as first and second, and the like are used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Without further limitation, the use of the verb "comprise a" to define an element does not exclude the presence of another, same element in a process, method, article, or apparatus that comprises the element.
Examples
Referring to fig. 1, an embodiment of the system for transmitting electrocardiosignals in vivo and in vitro according to the present invention is shown. In this embodiment, the system comprises an implantable electrocardiograph device 1(ICD), an RF base station 2 and a smartphone 3. The implantable electrocardiograph 1 includes an RF module 4 and an MCU 5 (control unit). The RF base station 2 includes an RF module 6, an MCU7, and a USB communication module 8. An APP with an emergency call function is installed in the smart phone 3. The Communication between the RF module 4 and the RF base station 2 adopts the standard of 400MHz Medical Implant Communication Service (MICS), and the general Communication distance is 2-5 m. The mobile phone is in seamless connection with modern people, and at present, few people can place the mobile phone at a place 3 meters away from the body. If the ICD equipment in the body monitors and confirms a malignant arrhythmia event, the ICD equipment is directly connected with an RF base station of a mobile phone through 400M (medical frequency band) to start calling for help and upload real-time electrocardiosignals; the effective communication distance of RF is typically within 3 meters. By using the system of the invention, the doctor can remotely obtain the information of the electrocardio equipment to make a judgment without going to the hospital for every half year of follow-up visit.
All documents referred to herein are incorporated by reference into this application as if each were individually incorporated by reference. Furthermore, it should be understood that various changes and modifications of the present invention can be made by those skilled in the art after reading the above teachings of the present invention, and these equivalents also fall within the scope of the present invention as defined by the appended claims.
Claims (9)
1. An in vivo and vitro electrocardiosignal transmission system is characterized by comprising an implanted electrocardio device, an electrocardiosignal transmission device and a mobile electronic device,
the electrocardiosignal transmission device is connected with the mobile electronic equipment;
when the electrocardiosignal transmission device is in a common monitoring state, the electrocardiosignal transmission device wakes up the implanted electrocardio equipment and reads data of the implanted electrocardio equipment; or in the emergency monitoring state, the implanted electrocardio-device wakes up the electrocardio-signal transmission device and enables the electrocardio-signal transmission device to read the data of the implanted electrocardio-device;
the implantable electrocardio device comprises an MCU control unit and an RF module; the MCU control unit is used for controlling the RF module; the RF module and the electrocardiosignal transmission device; the mobile electronic equipment is connected with a hospital database, and an APP with an emergency call function is installed on the mobile electronic equipment.
2. The system of claim 1, wherein the cardiac signal transmission device is connected to the mobile electronic device via USB;
the USB is standard USB or Mini USB.
3. The system of claim 1, wherein the implantable cardiac electrical device comprises a first control unit configured to control operation of the implantable cardiac electrical device.
4. The system of claim 1, wherein said cardiac signal transmission device comprises a second control unit for controlling the operation of said cardiac signal transmission device.
5. The system of claim 1, wherein the cardiac signal transmission device comprises a second RF module.
6. The system of claim 1, wherein the cardiac signal transmission device further comprises a USB communication module, and wherein the cardiac signal transmission device communicates with the mobile electronic device via the USB communication module.
7. The system of claim 1, wherein said cardiac signal transmission device is mounted on said mobile electronic device.
8. The system of claim 1, wherein the cardiac signal transmission device further comprises an alarm module.
9. The system of claim 1, wherein the ecg signal transmitting device is configured with a distance monitoring module for monitoring the distance between the implantable ecg device and the mobile electronic device.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810136461.XA CN108392183B (en) | 2018-02-09 | 2018-02-09 | In-vivo and in-vitro electrocardiosignal transmission system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810136461.XA CN108392183B (en) | 2018-02-09 | 2018-02-09 | In-vivo and in-vitro electrocardiosignal transmission system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108392183A CN108392183A (en) | 2018-08-14 |
| CN108392183B true CN108392183B (en) | 2021-03-26 |
Family
ID=63095567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810136461.XA Active CN108392183B (en) | 2018-02-09 | 2018-02-09 | In-vivo and in-vitro electrocardiosignal transmission system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108392183B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111714113A (en) * | 2020-04-30 | 2020-09-29 | 苏州无双医疗设备有限公司 | Implanted medical device for sensing electrocardiosignals |
| CN116616785A (en) * | 2023-07-26 | 2023-08-22 | 苏州维伟思医疗科技有限公司 | Heart treatment system and electrocardio monitoring data acquisition method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2724629Y (en) * | 2004-08-13 | 2005-09-14 | 北京蓝百通科技有限公司 | Zifeng domestic monitoring instrument for blood-pressure and pulse |
| CN204442424U (en) * | 2015-03-16 | 2015-07-01 | 北京品驰医疗设备有限公司 | A kind of long distance control system of implantable medical devices |
-
2018
- 2018-02-09 CN CN201810136461.XA patent/CN108392183B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2724629Y (en) * | 2004-08-13 | 2005-09-14 | 北京蓝百通科技有限公司 | Zifeng domestic monitoring instrument for blood-pressure and pulse |
| CN204442424U (en) * | 2015-03-16 | 2015-07-01 | 北京品驰医疗设备有限公司 | A kind of long distance control system of implantable medical devices |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108392183A (en) | 2018-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8155742B2 (en) | Remote communication system with availability indicator for an implantable medical device | |
| US9204795B2 (en) | Communication device, communication system and communication method for an implantable medical device | |
| US8744581B2 (en) | Cross-band communications in an implantable device | |
| US20080183245A1 (en) | Telemetry of external physiological sensor data and implantable medical device data to a central processing system | |
| US20040199212A1 (en) | External patient alerting system for implantable devices | |
| US9289614B2 (en) | System and method for communicating with an implantable medical device | |
| US20020045804A1 (en) | Information remote monitor (IRM) medical device | |
| CN204815373U (en) | Wearing formula intelligence defibrillator | |
| WO2002034331A2 (en) | Externally worn transceiver for use with an implantable medical device | |
| EP3422934A1 (en) | Reducing false positives in detection of potential cardiac pauses | |
| US20210383922A1 (en) | Method for Initiating a Data Transfer from an Implantable Medical Device | |
| CN108392183B (en) | In-vivo and in-vitro electrocardiosignal transmission system | |
| CN106357888A (en) | Electrocardiogram monitoring service system based on smart phone | |
| CN202488528U (en) | Real-time electrocardiogram monitoring cellphone | |
| US20200197710A1 (en) | Passive propagation fractal antenna for intrabody transmissions | |
| CN107212879A (en) | A kind of electrocardiosignal monitoring system | |
| CN101478914B (en) | Local communications network for distributed sensing and therapy in biomedical applications | |
| US8660659B2 (en) | Cross-band communications in an implantable device | |
| CN201481410U (en) | Automatic external defibrillator Bluetooth electrocardiogram monitoring device | |
| US9392940B2 (en) | Portable medical device for assistance to heart patients and method for processing and transmitting data through said device | |
| CN100389719C (en) | Household remote breathing electro cardiographic monitor | |
| CN110860041A (en) | Active awakening device and method for defibrillator | |
| US20140257849A1 (en) | Patient support apparatus configured for communicating with implantable devices | |
| CN211409053U (en) | A recovered device of intracardiac branch of academic or vocational study for data acquisition | |
| CN206060823U (en) | A kind of remote medical monitoring diagnostic system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |